Syncom Formulations – Pharma Formulations Manufacturer

Reading Time: 8 minutes

Dark Horse Stocks Home Page | Twitter Profile | Join Their Telegram Channel

Current Price-: 10.50 Rs

CAUTION

Please do not invest heavily in Penny stock ideas. Invest only that amount which you would be happy to loose as penny stocks are extremely risky and could lead to complete loss of capital

This company is engaged in manufacturing and markets more than 200 pharmaceutical formulations products in various dosage forms like Tablets, Capsules, Liquids Orals, Liquid Vials and Ampoule Injections & Dry Vial injections, Dry Syrups, Ointments, Inhalers and Herbals.

It is a renowned name in the Indian Pharmaceutical Industry represents synergistic combination of commitment and consistency.

Company possesses the manufacturing strength in its own manufacturing set-up at Pithampur (30kms away from Indore, the commercial capital of Madhya Pradesh, India).

Established in the year 1995, Company’s state of art WHO-GMP and ISO 9001-2008 certified plant is geared up with latest production machineries and maintains high quality standards. Currently Company manufactures and markets more than 300 pharmaceutical formulations products in various dosage forms like Tablets, Capsules, Liquids Orals, Liquid Vials and Ampoule Injections & Dry Vial injections, Dry Syrups, Ointments, Inhalers & Herbals.

Also Read on FinMedium:  Tata Power Valuation Excel Model and Intrinsic Value of Shares

The company’s marketing network is expanding globally. Currently,company operates in more than 15 countries worldwide having more than 400 products registered.

The company has earned clients’ and customers’ support due to its commitment and consistency in fulfilling the needs and demands of the patrons. Company’s Quality Products, Competitive Pricing, Prompt Delivery, Customer Service, Performance Consistency etc. enables the company to achieve customer delight.

Incorporated in 1988, it was only in 1994, the company undertook an expansion programme of setting up a new plant for manufacturing pharmaceutical formulations at Pithampur, Madhya Pradesh.

The project which was financed through a public issue made in Jan.’94 was completed in 1995.

During the year 1997-98, the Company has further diversified into Ethical Operations by introducing the range of prescription formulations.

During the year 1998-99 there has been huge expansion of installed capacity and production base. Further the company plans introduction of products in the generic, OTC and Ethical Divisions. The export earnings have also registered a growth of more than 100%.

During the year 1999-2000, the company and its associates have received export orders worth Rs.700.00 lacs against advance payment and hence better turnover was expected during the year.

Also Read on FinMedium:  10 interesting facts you didn't know about LIC

The company presently exports goods to Guine, Ghana, Kenya, Tanzania, Nigeria in Africa, Azberjan, Nepal and Srilanka in Asia. The company has been approved as a supplier to Central ESI Hospitals and registration of defence services is in its final stages, as a result of which will generate substantial sales volume.

Keeping in view the shifting consumer preferences for the use of herbal products, the company is aggressively manufacturing and marketing its herbal products like Edicare, Attom Megacaps, Ecziguard and Yas antacid salt.

Currently, company manufactures and markets more than 500 pharmaceutical formulations in various dosage forms like Tablets, Capsules, Liquids, Liquid ampoule & Dry vial injections, Dry syrups, Ointments, Inhalers & Herbals.

Today company has more than over 300 employees at its state-of-the-art manufacturing plant at Pithampur .

Business Products

Source link

Dark Horse Stocks Home Page | Twitter Profile | Join Their Telegram Channel

Disclaimer: The opinions expressed in this publication are those of the authors. They do not purport to reflect the opinions or views of the FinMedium or its members. The presentation of material therein does not imply the expression of any opinion whatsoever on the part of the FinMedium concerning the legal status of any company, country, area, or territory or of its authorities. For more info. please read our ToU & Privacy Policy here. If you have any concerns regarding this post, please reach out to our grievance officer Ghanisht Nagpal and drop a mail to editor@finmedium.com

Every Wednesday and Saturday, we send Info-Graphic and FinMedium Weekly Digest newsletters to our 25000+ Subscribers.

Join Them Now!


Dark Horse Stocks

Dark Horse Stocks

DHS aims to reach a wider audience by providing them with access to the data. Thereby helping them analyze financial reports and make their own investment decisions.
Please Share Now :)

Leave a Reply

Your email address will not be published. Required fields are marked *